This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.
January 2009
·
46 Reads
·
2 Citations
The Journal of family practice
Prophylactic oxytocin is fine before or after placental delivery. Timing alone doesn't influence the drug's efficacy in preventing postpartum bleeding (recommendation based on randomized controlled trial and prospective cohort studies).
... Oxytocin acts quickly and effectively with minimal adverse effects and can be used in all women, which makes it the main interven- tion for reducing PPH and is the first uterotonic drug option (23). The administration of oxytocin during the TSL reduces the risk of PPH by 40% (24). Immediately after fetal delivery, starting intravenous infusion of 20 IU of oxytocin in 500 mL RL and given within 2 hours is the routine protocol in our institute for AMTSL. ...
January 2009
The Journal of family practice
